AACR logo

More articles from Review

Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides
Jamie V. Shiah, Jennifer R. Grandis, Daniel E. Johnson

Molecular Cancer Therapeutics Nov 2020, DOI: 10.1158/1535-7163.MCT-20-0599
Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer
Rachel K. Toth, Noel A. Warfel

Molecular Cancer Therapeutics Jan 2021, 20 (1) 3-10; DOI: 10.1158/1535-7163.MCT-20-0535
Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer
Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, Iqbal S. Grewal

Molecular Cancer Therapeutics Dec 2020, 19 (12) 2409-2421; DOI: 10.1158/1535-7163.MCT-20-0385
Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
Aamod S. Dekhne, Zhanjun Hou, Aleem Gangjee, Larry H. Matherly

Molecular Cancer Therapeutics Nov 2020, 19 (11) 2245-2255; DOI: 10.1158/1535-7163.MCT-20-0423
Ion Channels and Their Role in the Pathophysiology of Gliomas
Takeshi Takayasu, Kaoru Kurisu, Yoshua Esquenazi, Leomar Y. Ballester

Molecular Cancer Therapeutics Oct 2020, 19 (10) 1959-1969; DOI: 10.1158/1535-7163.MCT-19-0929
Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
Patrick J. Roberts, Vishnu Kumarasamy, Agnieszka K. Witkiewicz, Erik S. Knudsen

Molecular Cancer Therapeutics Aug 2020, 19 (8) 1575-1588; DOI: 10.1158/1535-7163.MCT-18-1161
A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
Lihua Shu, Dongsheng Wang, Nabil F. Saba, Zhuo G. Chen

Molecular Cancer Therapeutics Apr 2020, 19 (4) 999-1007; DOI: 10.1158/1535-7163.MCT-19-0660
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
Scott F. Schoninger, Stacy W. Blain

Molecular Cancer Therapeutics Jan 2020, 19 (1) 3-12; DOI: 10.1158/1535-7163.MCT-19-0253
Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Paulo Bergerot, Peter Lamb, Evelyn Wang, Sumanta K. Pal

Molecular Cancer Therapeutics Dec 2019, 18 (12) 2185-2193; DOI: 10.1158/1535-7163.MCT-18-1399
Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
Benjamin L. Woolbright, Ganeshkumar Rajendran, Robert A. Harris, John A. Taylor

Molecular Cancer Therapeutics Oct 2019, 18 (10) 1673-1681; DOI: 10.1158/1535-7163.MCT-19-0079

Main menu

User menu

Search

More articles from Review

Pages

Articles

Info for

About MCT